Showing results (81-90 of 1,686) with videos related to
Sort By:
Pageof 169
Annals of Diagnostic Pathology|May 30, 2018
Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancersMopei Wang, Li Liang, Xiudong Lei, et al.Pharmacology & Therapeutics|February 9, 2017
Targeting TRK family proteins in cancerYekaterina B Khotskaya, Vijaykumar R Holla, Anna F Farago, et al.Current Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep TaberneroCancer Cell|December 15, 2020
The Effective Targeting of KRASG12C ElusivenessElena Elez, Josep TaberneroCancer Discovery|July 8, 2017
Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the DarknessJordi Rodon, Josep TaberneroCancer Discovery|May 16, 2012
A shining light in the darkness for the treatment of pancreatic neuroendocrine tumorsJaume Capdevila, Josep TaberneroCurrent Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Necitumumab, a fully human IgG1 mAb directed against the EGFR for the potential treatment of cancerRodrigo Dienstmann, Josep TaberneroCancer Discovery|March 5, 2013
Molecular dissection of microsatellite instable colorectal cancerEduardo Vilar, Josep TaberneroAnti-Cancer Agents in Medicinal Chemistry|March 24, 2011
BRAF as a target for cancer therapyRodrigo Dienstmann, Josep TaberneroCancer Journal (Sudbury, Mass.)|June 25, 2016
Spectrum of Gene Mutations in Colorectal Cancer: Implications for TreatmentRodrigo Dienstmann, Josep TaberneroPageof 169